Lightox has developed a unique range of molecular tools for use in imaging, therapeutics and assay development.
Lightox has raised $1.9M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2024.
Lightox's investors include Northstar Ventures, Praetura Ventures, Innovate UK.
Lightox is headquartered in Billingham, United Kingdom.
Lightox has developed a unique range of molecular tools for use in imaging, therapeutics and assay development.
Lightox is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Lightox — Funding & Investors." VCBacked, May 3, 2024, https://www.vcbacked.co/company/lightox. Accessed August 15, 2026.
VCBacked. (2024). Lightox — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/lightox
{{cite web |title=Lightox — Funding & Investors |url=https://www.vcbacked.co/company/lightox |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated